Keystone Wealth Services LLC Lowers Stock Holdings in Cardinal Health, Inc. $CAH

Keystone Wealth Services LLC reduced its stake in Cardinal Health, Inc. (NYSE:CAH) by 2.7% during the 2nd quarter, HoldingsChannel reports. The firm owned 2,908 shares of the company’s stock after selling 80 shares during the period. Keystone Wealth Services LLC’s holdings in Cardinal Health were worth $488,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Greykasell Wealth Strategies Inc. purchased a new position in shares of Cardinal Health in the 1st quarter valued at approximately $26,000. Tompkins Financial Corp grew its stake in shares of Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock valued at $34,000 after purchasing an additional 128 shares during the last quarter. GW&K Investment Management LLC grew its stake in shares of Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after purchasing an additional 144 shares during the last quarter. NBC Securities Inc. purchased a new stake in shares of Cardinal Health in the first quarter valued at approximately $48,000. Finally, Zions Bancorporation National Association UT purchased a new stake in shares of Cardinal Health in the first quarter valued at approximately $52,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Michelle D. Greene sold 13,500 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the business’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the sale, the insider directly owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 271,676 shares of company stock valued at $40,489,525. Corporate insiders own 0.09% of the company’s stock.

Cardinal Health Trading Down 1.2%

Cardinal Health stock opened at $148.44 on Wednesday. The firm has a market capitalization of $35.45 billion, a P/E ratio of 23.01, a PEG ratio of 1.27 and a beta of 0.73. The stock has a fifty day moving average price of $153.84 and a 200 day moving average price of $148.08. Cardinal Health, Inc. has a 52 week low of $106.54 and a 52 week high of $168.44.

Cardinal Health (NYSE:CAH) last released its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio is presently 31.63%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the company. Robert W. Baird lifted their price target on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Argus set a $189.00 price target on Cardinal Health in a research note on Friday, August 22nd. Bank of America lifted their price target on Cardinal Health from $165.00 to $170.00 and gave the company a “buy” rating in a research note on Tuesday, June 10th. Evercore ISI decreased their price target on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 13th. Finally, Leerink Partners decreased their target price on Cardinal Health from $188.00 to $186.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 12th. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $165.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.